Treats hypertension. ANDA 77690, held by Lupin. Quinapril Hydrochloride.
As of Nov 16, 2026, ANDA 77690 (Quinapril Hydrochloride), held by Lupin, was first approved by FDA on Jun 20, 2006, with 11 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Hypertension Quinapril tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril tablets USP.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 2006 | Original application | Approved | None posted |
| Quinapril HydrochlorideEQ 5MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Quinapril HydrochlorideEQ 10MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Quinapril HydrochlorideEQ 20MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Quinapril HydrochlorideEQ 40MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Jul 19, 2018 | Supplement 29Labeling · Standard review | Approved | None posted |
| Jul 19, 2018 | Supplement 30Labeling · Standard review | Approved | None posted |
| Feb 18, 2016 | Supplement 26Labeling · Standard review | Approved | None posted |
| Sep 26, 2014 | Supplement 22Labeling · Standard review | Approved | None posted |
| Sep 26, 2014 | Supplement 24Labeling · Standard review | Approved | None posted |
| Sep 26, 2014 | Supplement 25Labeling · Standard review | Approved | None posted |
| Dec 14, 2012 | Supplement 17Labeling | Approved | None posted |
| Dec 14, 2012 | Supplement 19Labeling · Standard review | Approved | None posted |
| Sep 17, 2010 | Supplement 15Labeling | Approved | None posted |
| Feb 15, 2008 | Supplement 2Labeling | Approved | None posted |
| Oct 23, 2007 | Supplement 4Labeling | Approved | None posted |
| Jun 20, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters